期刊文献+

植物凝集素样氧化型低密度脂蛋白受体-1与动脉粥样硬化 被引量:8

Lectin-like oxidized low-density lipoprotein receptor-1 and atherosclerosis
原文传递
导出
摘要 植物凝集素样氧化型低密度脂蛋白受体-1(lectin-likeoxidizedlow-densitylipoprotein receptor-1, LOX-1)是氧化型低密度脂蛋白(oxidized low-density lipoproteins, oxLDL)的主要受体之一。近年来的研究表明,LOX-1不仅可以结合、中和以及降解oxLDL,还能与一些非氧化脂蛋白和凋亡的血细胞结合,通过激活血小板、诱导炎症反应、促进血管平滑肌细胞增殖和迁移等多种途径参与动脉粥样硬化进程。文章从LOX-1的结构、功能及其与脂质代谢、动脉粥样硬化发病机制间的关系等方面,对相关研究进展进行了综述。 Lectin-likeoxidizedLDLreceptor-1(LOX-1)isoneofthemajorreceptorsoftheoxidized low-density lipoproteins (oxLDL). Recent research suggests that LOX-1 can not only bind, neutralize and degrade oxLDL, but also bind some non-oxidized lipoproteins and apoptotic blood cel s. LOX-1 is involved in the process of atherosclerosis through a variety of w ays, such as activating platelet, inducing inflammatory reaction, promoting the proliferation and migration of vascular smooth muscle cels. This article reviews the related research progress from the relationship betw een the structure and function of the LOX-1 and its lipid metabolism and the pathogenesis of atherosclerosis.
出处 《国际脑血管病杂志》 2015年第2期145-150,共6页 International Journal of Cerebrovascular Diseases
基金 国家自然科学基金青年科学基金项目(81200894) 江苏省自然科学基金青年基金项目(SBK201241136) 教育部高等学校博士学科点专项科研基金(20113201120016) 苏州大学青年科学基金(SDY2011A44) 苏州市科技发展计划指导项目(sysd2012083)
关键词 动脉粥样硬化 清除剂受体 E类 炎症 LDL Atherosclerosis ScavengerReceptors,ClassE Lipoproteins,LDL Inflammation
  • 相关文献

同被引文献53

  • 1丁元庆,屈静,杨军.从火热论颈动脉粥样硬化的病机与治疗[J].山东中医杂志,2007,26(3):147-149. 被引量:43
  • 2谭玉林,莫中成,易光辉.动脉粥样硬化早期病变过程CD36的表达与oxLDL的摄取作用[J].生命的化学,2005,25(1):7-10. 被引量:2
  • 3吴立文,林华.我国癫外科术前评估的现状和存在的问题[J].中华医学杂志,2006,86(47):3313-3314. 被引量:6
  • 4Khan SA,Dong H,Joyce J,et al. Fibulin-2 is essential for angiotensinII-induced myocardial fibrosis mediated by transforming growthfactor (TGF)-β[J]. Lab Invest,2016,24(2):78-80.
  • 5Liu G,Liang B,Song X,et al. P-selectin increases angiotensin IIinduced cardiac inflammation and fibrosis via platelet activation[J].Mol Med Rep,2016,2(4):63-9.
  • 6Bai F,Pang XF,Zhang LH,et al. Angiotensin II AT1 receptoralters ACE2 activity, eNOS expression and CD44-hyaluronaninteraction in rats with hypertension and myocardial fibrosis[J]. LifeSci,2016,2(2):72-5.
  • 7Pang XF,Zhang LH,Bai F,et al. Attenuation of myocardial fibrosiswith curcumin is mediated by modulating expression of angiotensinII AT1/AT2 receptors and ACE2 in rats[J]. Drug Des DevelTher,2015,12(2):45-8.
  • 8Watanabe R,Suzuki J,Wakayama K,et al. Angiotensin II receptorblocker irbesartan attenuates cardiac dysfunction induced bymyocardial infarction in the presence of renal failure[J]. HypertensRes,2016,39(4):237-44.
  • 9Yang G,Wang Y,Zeng Y,et al.Rapid health transition in China,1990-2010:findings from the Global Burden of Disease Study 2010[J1. The Lancet, 2013,381(9882) : 1987-2015.
  • 10Liang Z,Han R,Qu Y,et al. placement in the endovascular thrombosis in the central veins [J] 57 -62. Role of prophylactic filter treatment of symptomatic Thromb Res, 2014,134( 1 ) :.

引证文献8

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部